REIT - Residential
Compare Stocks
5 / 10Stock Comparison
BHM vs WELL vs VTR vs AMH vs EQR
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Residential
REIT - Residential
BHM vs WELL vs VTR vs AMH vs EQR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Residential | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Residential | REIT - Residential |
| Market Cap | $45M | $149.25B | $41.15B | $11.77B | $24.68B |
| Revenue (TTM) | $72M | $11.63B | $6.13B | $1.87B | $3.12B |
| Net Income (TTM) | $-8M | $1.43B | $260M | $467M | $954M |
| Gross Margin | 57.3% | 39.1% | -4.3% | 30.2% | 46.3% |
| Operating Margin | 51.9% | 4.4% | 13.4% | 25.0% | 28.5% |
| Forward P/E | — | 78.4x | 118.0x | 44.7x | 50.6x |
| Total Debt | $437M | $21.38B | $13.22B | $5.13B | $8.78B |
| Cash & Equiv. | $170M | $5.03B | $741M | $109M | $56M |
BHM vs WELL vs VTR vs AMH vs EQR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 22 | May 26 | Return |
|---|---|---|---|
| Bluerock Homes Trus… (BHM) | 100 | 54.0 | -46.0% |
| Welltower Inc. (WELL) | 100 | 331.2 | +231.2% |
| Ventas, Inc. (VTR) | 100 | 215.4 | +115.4% |
| American Homes 4 Re… (AMH) | 100 | 98.8 | -1.2% |
| Equity Residential (EQR) | 100 | 98.0 | -2.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BHM vs WELL vs VTR vs AMH vs EQR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BHM is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 36.9%, EPS growth -174.5%, 3Y rev CAGR 17.2%
- 36.9% FFO/revenue growth vs EQR's 4.1%
WELL ranks third and is worth considering specifically for long-term compounding and sleep-well-at-night.
- 223.1% 10Y total return vs VTR's 65.0%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- +42.7% vs AMH's -13.3%
VTR is the clearest fit if your priority is stability.
- Beta 0.01 vs EQR's 0.38
AMH is the clearest fit if your priority is valuation efficiency and defensive.
- PEG 1.34 vs EQR's 9.94
- Beta 0.17, yield 3.8%, current ratio 62.90x
- Lower P/E (44.7x vs 50.6x), PEG 1.34 vs 9.94
EQR carries the broadest edge in this set and is the clearest fit for income & stability.
- Dividend streak 8 yrs, beta 0.38, yield 4.1%
- 30.6% margin vs BHM's -11.0%
- 4.1% yield, 8-year raise streak, vs AMH's 3.8%, (1 stock pays no dividend)
- 4.6% ROA vs BHM's -0.7%, ROIC 4.2% vs -2.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 36.9% FFO/revenue growth vs EQR's 4.1% | |
| Value | Lower P/E (44.7x vs 50.6x), PEG 1.34 vs 9.94 | |
| Quality / Margins | 30.6% margin vs BHM's -11.0% | |
| Stability / Safety | Beta 0.01 vs EQR's 0.38 | |
| Dividends | 4.1% yield, 8-year raise streak, vs AMH's 3.8%, (1 stock pays no dividend) | |
| Momentum (1Y) | +42.7% vs AMH's -13.3% | |
| Efficiency (ROA) | 4.6% ROA vs BHM's -0.7%, ROIC 4.2% vs -2.0% |
BHM vs WELL vs VTR vs AMH vs EQR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BHM vs WELL vs VTR vs AMH vs EQR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EQR leads in 2 of 6 categories
BHM leads 1 • WELL leads 1 • VTR leads 1 • AMH leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — BHM and WELL each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 161.5x BHM's $72M. EQR is the more profitable business, keeping 30.6% of every revenue dollar as net income compared to BHM's -11.0%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $72M | $11.6B | $6.1B | $1.9B | $3.1B |
| EBITDAEarnings before interest/tax | $67M | $2.8B | $2.3B | $973M | $1.9B |
| Net IncomeAfter-tax profit | -$8M | $1.4B | $260M | $467M | $954M |
| Free Cash FlowCash after capex | $995,000 | $2.5B | $1.4B | $875M | $1.3B |
| Gross MarginGross profit ÷ Revenue | +57.3% | +39.1% | -4.3% | +30.2% | +46.3% |
| Operating MarginEBIT ÷ Revenue | +51.9% | +4.4% | +13.4% | +25.0% | +28.5% |
| Net MarginNet income ÷ Revenue | -11.0% | +12.3% | +4.2% | +25.0% | +30.6% |
| FCF MarginFCF ÷ Revenue | +1.4% | +21.9% | +22.4% | +46.9% | +42.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +20.0% | +40.3% | +22.0% | +2.8% | +2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -34.3% | +22.5% | 0.0% | +16.7% | -64.2% |
Valuation Metrics
BHM leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 22.6x trailing earnings, EQR trades at a 86% valuation discount to VTR's 160.3x P/E. Adjusting for growth (PEG ratio), AMH offers better value at 0.82x vs EQR's 4.44x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $45M | $149.2B | $41.1B | $11.8B | $24.7B |
| Enterprise ValueMkt cap + debt − cash | $312M | $165.6B | $53.6B | $16.8B | $33.4B |
| Trailing P/EPrice ÷ TTM EPS | -3.62x | 153.25x | 160.26x | 27.47x | 22.63x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 78.42x | 118.01x | 44.67x | 50.61x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.82x | 4.44x |
| EV / EBITDAEnterprise value multiple | 50.76x | 66.40x | 24.31x | 17.56x | 15.61x |
| Price / SalesMarket cap ÷ Revenue | 0.65x | 13.99x | 7.05x | 6.31x | 7.96x |
| Price / BookPrice ÷ Book value/share | 0.06x | 3.35x | 3.18x | 1.56x | 2.24x |
| Price / FCFMarket cap ÷ FCF | 4.31x | 52.41x | 31.25x | 15.78x | 19.13x |
Profitability & Efficiency
EQR leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
EQR delivers a 8.4% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $-1 for BHM. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to VTR's 1.05x. On the Piotroski fundamental quality scale (0–9), BHM scores 7/9 vs EQR's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -1.3% | +3.5% | +2.1% | +6.0% | +8.4% |
| ROA (TTM)Return on assets | -0.7% | +2.3% | +1.0% | +3.5% | +4.6% |
| ROICReturn on invested capital | -2.0% | +0.5% | +2.5% | +2.7% | +4.2% |
| ROCEReturn on capital employed | -2.4% | +0.6% | +3.2% | +3.4% | +5.7% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 6 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.63x | 0.49x | 1.05x | 0.66x | 0.77x |
| Net DebtTotal debt minus cash | $268M | $16.3B | $12.5B | $5.0B | $8.7B |
| Cash & Equiv.Liquid assets | $170M | $5.0B | $741M | $109M | $56M |
| Total DebtShort + long-term debt | $437M | $21.4B | $13.2B | $5.1B | $8.8B |
| Interest CoverageEBIT ÷ Interest expense | -0.43x | 0.26x | 1.40x | 3.77x | 5.58x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $5,901 for BHM. Over the past 12 months, WELL leads with a +42.7% total return vs AMH's -13.3%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs BHM's -10.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -4.2% | +14.3% | +12.6% | +2.6% | +8.4% |
| 1-Year ReturnPast 12 months | +10.3% | +42.7% | +33.9% | -13.3% | -2.7% |
| 3-Year ReturnCumulative with dividends | -27.7% | +189.5% | +94.2% | +1.5% | +17.5% |
| 5-Year ReturnCumulative with dividends | -41.0% | +202.3% | +74.8% | -1.4% | +6.7% |
| 10-Year ReturnCumulative with dividends | -41.0% | +223.1% | +65.0% | +116.9% | +29.3% |
| CAGR (3Y)Annualised 3-year return | -10.2% | +42.5% | +24.8% | +0.5% | +5.5% |
Risk & Volatility
VTR leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
VTR is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than EQR's 0.38 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 97.8% from its 52-week high vs BHM's 73.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.32x | 0.13x | 0.01x | 0.17x | 0.38x |
| 52-Week HighHighest price in past year | $14.81 | $219.59 | $88.50 | $39.07 | $71.80 |
| 52-Week LowLowest price in past year | $8.05 | $142.65 | $61.76 | $27.21 | $57.58 |
| % of 52W HighCurrent price vs 52-week peak | +73.8% | +97.0% | +97.8% | +83.0% | +91.7% |
| RSI (14)Momentum oscillator 0–100 | 44.6 | 60.2 | 56.2 | 72.8 | 69.8 |
| Avg Volume (50D)Average daily shares traded | 8K | 2.6M | 3.4M | 3.4M | 2.4M |
Analyst Outlook
EQR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: WELL as "Buy", VTR as "Buy", AMH as "Buy", EQR as "Hold". Consensus price targets imply 8.0% upside for AMH (target: $35) vs 4.9% for VTR (target: $91). For income investors, EQR offers the higher dividend yield at 4.09% vs WELL's 1.30%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $226.50 | $90.80 | $35.00 | $70.15 |
| # AnalystsCovering analysts | — | 34 | 32 | 36 | 46 |
| Dividend YieldAnnual dividend ÷ price | — | +1.3% | +2.1% | +3.8% | +4.1% |
| Dividend StreakConsecutive years of raises | 1 | 2 | 1 | 5 | 8 |
| Dividend / ShareAnnual DPS | — | $2.76 | $1.86 | $1.24 | $2.69 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.9% | 0.0% | 0.0% | +1.4% | +1.1% |
EQR leads in 2 of 6 categories (Profitability & Efficiency, Analyst Outlook). BHM leads in 1 (Valuation Metrics). 1 tied.
BHM vs WELL vs VTR vs AMH vs EQR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BHM or WELL or VTR or AMH or EQR a better buy right now?
For growth investors, Bluerock Homes Trust, Inc.
(BHM) is the stronger pick with 36. 9% revenue growth year-over-year, versus 4. 1% for Equity Residential (EQR). Equity Residential (EQR) offers the better valuation at 22. 6x trailing P/E (50. 6x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BHM or WELL or VTR or AMH or EQR?
On trailing P/E, Equity Residential (EQR) is the cheapest at 22.
6x versus Ventas, Inc. at 160. 3x. On forward P/E, American Homes 4 Rent is actually cheaper at 44. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: American Homes 4 Rent wins at 1. 34x versus Equity Residential's 9. 94x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — BHM or WELL or VTR or AMH or EQR?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to -41. 0% for Bluerock Homes Trust, Inc. (BHM). Over 10 years, the gap is even starker: WELL returned +223. 1% versus BHM's -41. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BHM or WELL or VTR or AMH or EQR?
By beta (market sensitivity over 5 years), Ventas, Inc.
(VTR) is the lower-risk stock at 0. 01β versus Equity Residential's 0. 38β — meaning EQR is approximately 3861% more volatile than VTR relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 105% for Ventas, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BHM or WELL or VTR or AMH or EQR?
By revenue growth (latest reported year), Bluerock Homes Trust, Inc.
(BHM) is pulling ahead at 36. 9% versus 4. 1% for Equity Residential (EQR). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -174. 5% for Bluerock Homes Trust, Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BHM or WELL or VTR or AMH or EQR?
Equity Residential (EQR) is the more profitable company, earning 36.
1% net margin versus 3. 3% for Bluerock Homes Trust, Inc. — meaning it keeps 36. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EQR leads at 36. 3% versus -33. 8% for BHM. At the gross margin level — before operating expenses — EQR leads at 46. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BHM or WELL or VTR or AMH or EQR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, American Homes 4 Rent (AMH) is the more undervalued stock at a PEG of 1. 34x versus Equity Residential's 9. 94x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, American Homes 4 Rent (AMH) trades at 44. 7x forward P/E versus 118. 0x for Ventas, Inc. — 73. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMH: 8. 0% to $35. 00.
08Which pays a better dividend — BHM or WELL or VTR or AMH or EQR?
In this comparison, EQR (4.
1% yield), AMH (3. 8% yield), VTR (2. 1% yield), WELL (1. 3% yield) pay a dividend. BHM does not pay a meaningful dividend and should not be held primarily for income.
09Is BHM or WELL or VTR or AMH or EQR better for a retirement portfolio?
For long-horizon retirement investors, Ventas, Inc.
(VTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), 2. 1% yield). Both have compounded well over 10 years (VTR: +65. 0%, BHM: -41. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BHM and WELL and VTR and AMH and EQR?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BHM is a small-cap high-growth stock; WELL is a mid-cap high-growth stock; VTR is a mid-cap high-growth stock; AMH is a mid-cap income-oriented stock; EQR is a mid-cap income-oriented stock. WELL, VTR, AMH, EQR pay a dividend while BHM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.